These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7352718)

  • 1. Chronic obstructive pulmonary disease: a community-oriented program including professional education and screening by a voluntary health agency.
    Hepper NG; Drage CW; Davies SF; Rupp WM; LaMothe J; Schoenfelder PG; Munson P
    Am Rev Respir Dis; 1980 Jan; 121(1):97-104. PubMed ID: 7352718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A test for early detection of COPD].
    Czajkowska-Malinowska M; Zieliński J
    Pneumonol Alergol Pol; 2000; 68(5-6):207-12. PubMed ID: 11004857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The majority of participants with abnormal spirometry at walk-in consult their general practitioner as recommended.
    Kølner-Augustson L; Thøgersen N; Faaborg TH; Weinreich UM
    Dan Med J; 2015 Nov; 62(11):A5149. PubMed ID: 26522482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist-managed chronic obstructive pulmonary disease screening in a community setting.
    Fuller L; Conrad WF; Heaton PC; Panos R; Eschenbacher W; Frede SM
    J Am Pharm Assoc (2003); 2012; 52(5):e59-66. PubMed ID: 22975798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program.
    van den Boom G; van Schayck CP; van Möllen MP; Tirimanna PR; den Otter JJ; van Grunsven PM; Buitendijk MJ; van Herwaarden CL; van Weel C
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1730-8. PubMed ID: 9847260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voluntary school screening for scoliosis in Minnesota.
    Lonstein JE; Bjorklund S; Wanninger MH; Nelson RP
    J Bone Joint Surg Am; 1982 Apr; 64(4):481-8. PubMed ID: 6802853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
    Vestbo J; Prescott E; Lange P
    Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host factors in chronic obstructive pulmonary disease in an upper Midwest rural community. Design, case selection, and clinical characteristics in a matched-pair study.
    Miller RD; Hepper NG; Kueppers F; Gordon H; Offord KP
    Mayo Clin Proc; 1976 Nov; 51(11):709-15. PubMed ID: 1086934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who comes to voluntary, community-based alcohol screening? Results of the first annual National Alcohol Screening Day, 1999.
    Greenfield SF; Keliher A; Sugarman D; Kozloff R; Reizes JM; Kopans B; Jacobs D
    Am J Psychiatry; 2003 Sep; 160(9):1677-83. PubMed ID: 12944345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of early airway disease in smokers: cost effectiveness of pulmonary function testing.
    Loss RW; Hall WJ; Speers DM
    Am J Med Sci; 1979; 278(1):27-37. PubMed ID: 114050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Applicability of a multi-dimensional analysis of forced expiratory flow rates in mass screening].
    Fischer J; Louton T; Rühle KH; Cegla UH; Matthys H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1475-7. PubMed ID: 611870
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of spirometric screening in the community on smoking cessation].
    Czajkowska-Malinowska M; Nowiński A; Górecka D; Zieliński J
    Pneumonol Alergol Pol; 2001; 69(9-10):524-9. PubMed ID: 11928658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic obstructive pulmonary disease and '150 years of blowing'.
    Miller MR
    Hosp Med; 1998 Sep; 59(9):719-22. PubMed ID: 9829080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for screening spirometry?
    MacIntyre NR; Selecky PA
    Respir Care; 2010 Jan; 55(1):35-42. PubMed ID: 20040122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mayo Three-Community Hypertension Control Program. I. Design and initial screening results.
    Labarthe DR; Krishan I; Nobrega FT; Brennan LA; Smoldt RK; Mori HD; Hunt JC
    Mayo Clin Proc; 1979 May; 54(5):289-98. PubMed ID: 431130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of the forced expiratory time in the physical diagnosis of obstructive airways disease.
    Schapira RM; Schapira MM; Funahashi A; McAuliffe TL; Varkey B
    JAMA; 1993 Aug; 270(6):731-6. PubMed ID: 8336375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inspiratory flow-volume curve evaluation for detecting upper airway disease.
    Sterner JB; Morris MJ; Sill JM; Hayes JA
    Respir Care; 2009 Apr; 54(4):461-6. PubMed ID: 19327180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of PM10 pollution on pulmonary function of smokers with mild to moderate chronic obstructive pulmonary disease.
    Pope CA; Kanner RE
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1336-40. PubMed ID: 8503541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program.
    Ferguson GT; Enright PL; Buist AS; Higgins MW
    Respir Care; 2000 May; 45(5):513-30. PubMed ID: 10813228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.